Outcomes sensitive to nursing service quality in ambulatory cancer chemotherapy: systematic scoping review by Griffiths, Peter et al.
                             Elsevier Editorial System(tm) for European Journal of Oncology Nursing 
                                  Manuscript Draft 
 
 
Manuscript Number:  
 
Title: Outcomes sensitive to nursing service quality in ambulatory cancer chemotherapy: systematic 
scoping review  
 
Article Type: Full Length Article 
 
Keywords: Quality measurement, outcomes, chemotherapy, nursing, clinical nurse specialists, 
ambulatory care 
 
Corresponding Author: Professor Peter Griffiths,  
 
Corresponding Author's Institution: University of Southamton 
 
First Author: Peter Griffiths 
 
Order of Authors: Peter Griffiths; Alison Richardson; Rebecca Blackwell 
 
Abstract: Background: There is long standing interest in identifying patient outcomes that are sensitive 
to nursing care and an increasing number of systems that include outcomes in order to demonstrate or 
monitor the quality of nursing care. 
Objective:  We undertook scoping reviews of the literature in order to identify patient outcomes 
sensitive to the quality of nursing services in ambulatory cancer chemotherapy settings to guide the 
development of an outcomes based quality measurement system. 
Methods: A 2 stage scoping review to identify potential outcome areas which were subsequently 
assessed for their sensitivity to nursing. Data sources included the Cochrane Library, Medline, Embase, 
the British Nursing Index, Google and Google scholar 
Results: We identified a broad range of outcomes potentially sensitive to nursing. Individual trials 
support many nursing interventions but we found relatively little clear evidence of effect on outcomes 
derived from a systematic reviews and no evidence associating characteristics of nursing services with 
outcomes.  
Conclusion: The purpose of identifying a set of outcomes as specifically nurse-sensitive for quality 
measurement is to give clear responsibility and create an expectation of strong clinical leadership by 
nurses in terms of monitoring and acting on results. It is important to select those outcomes that 
nurses have most impact upon. .Patient experience, nausea and vomiting, mucositis and safe 
medication administration were outcome areas most likely to yield sensitive measures of nursing 
service quality in ambulatory cancer chemotherapy.  
 
 
Suggested Reviewers: Michael Simon PhD 
Associate Professor, University of Kansas 
msimon@kumc.edu 
Expert on nursing quality outcomes measures 
 
Nancy Donaldson PhD 
UCSF 
nancy.donaldson@nursing.ucsf.edu 
Expert on nursing / quality / outcome measurements 
 
 
 
 
National Nursing 
Research Unit 
Professor Peter Griffiths 
Director 
020 7848 3012/3057 
peter.griffiths@kcl.ac.uk 
James Clerk Maxwell Building 
Waterloo Campus 
57 Waterloo Road 
London SE1 8WA 
Telephone 020 7848 3057 
Fax 020 7848 3069 
 
    
http://www.kcl.ac.uk/schools/nursing/nnru 
 
Dear Professor Molassiotis 
 
Please find our manuscript, which we ask you to consider for Publication the European 
Journal of Oncology Nursing 
 
All authors contributed significantly to the conception writing and revision of the paper 
and meet the criteria for authorship. We have no conflicts of interest of which we are 
aware. 
 
Yours Sincerely 
 
 
 
 
 
 
Peter Griffiths 
*Cover Letter
Conflict of Interest Statement 
 
None 
*Conflict of Interest Statement
Outcomes sensitive to nursing service quality in ambulatory cancer 
chemotherapy: systematic scoping review 
 
Peter Griffiths PhD, Alison Richardson PhD, Rebecca Blackwell RN 
School of Health Sciences, University of Southampton, Southampton, England (Griffiths, Richardson), 
Southampton University Hospitals NHS Trust , Southampton, England(Richardson) 
National Nursing Research Unit, King’s College London, London, England (Griffiths, B lackwell), 
 
Correspondence 
Professor Peter Griffiths 
Chair of Health Services Research 
University of Southampton  
School of Health Sciences 
Room E4015, Building 67 
Highfield Campus 
SO17 1BJ 
 
+44(0)2380597877 
peter.griffiths@southampton.ac.uk 
 
Authors' contributions 
Griffiths – design of study, review and selection of papers, drafting paper, approval of final version 
Richardson - design of study, drafting paper, approval of final version 
Blackwell – literature searching, review and selection of papers, drafting paper, approval of final 
version 
 
 
 
 
*Title Page (with authors and addresses)
Outcomes sensitive to nursing service quality in ambulatory cancer 
chemotherapy: literature review 
Abstract  
Background: There is long standing interest in identifying patient outcomes that are 
sensitive to nursing care and an increasing number of systems that include outcomes in 
order to demonstrate or monitor the quality of nursing care. 
Objective:  We undertook scoping reviews of the literature in order to identify patient 
outcomes sensitive to the quality of nursing services in ambulatory cancer chemotherapy 
settings to guide the development of an outcomes based quality measurement system. 
Methods: A 2 stage scoping review to identify potential outcome areas which were 
subsequently assessed for their sensitivity to nursing. Data sources included the Cochrane 
Library, Medline, Embase, the British Nursing Index, Google and Google scholar 
Results: We identified a broad range of outcomes potentially sensitive to nursing. Individual 
trials support many nursing interventions but we found relatively little clear evidence of effect 
on outcomes derived from a systematic reviews and no evidence associating characteristics 
of nursing services with outcomes.  
Conclusion: The purpose of identifying a set of outcomes as specifically nurse-sensitive for 
quality measurement is to give clear responsibility and create an expectation of strong 
clinical leadership by nurses in terms of monitoring and acting on results. It is important to 
select those outcomes that nurses have most impact upon. .Patient experience, nausea and 
vomiting, mucositis and safe medication administration were outcome areas most likely to 
yield sensitive measures of nursing service quality in ambulatory cancer chemotherapy.  
Key words 
Quality measurement, outcomes, chemotherapy, nursing, clinical nurse specialists, 
ambulatory care 
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Outcomes sensitive to nursing service quality in ambulatory cancer 
chemotherapy: systematic scoping review 
Background  
 
Introduction 
There is a long standing and enduring interest in identifying patient outcomes that are sensitive to 
nursing care. There are an increasing number of measurement systems that include or focus on 
outcomes in order to demonstrate or monitor the quality of nursing care. The most notable and 
probably the largest scale examples are widely implemented in US hospitals: for example 
Collaborative Alliance for Nursing Outcomes (CALNOC) and the American Nurse‟s Association 
backed National Database of Nursing Quality Indicators
TM
 (NDNQI
®
). These systems allow 
benchmarking of performance between comparable units and enable individual clinical units to 
monitor the quality of care delivered over time. While such systems are by no means exclusively 
targeted at acute inpatient settings, the vast majority of development has been undertaken in 
such areas (Griffiths et al., 2008a), although there are several extensive reviews which identify 
outcomes that are potentially sensitive to nursing care in a range of settings and specialties 
(e.g.Doran, 2003), including cancer care (e.g.Gobel et al., 2006). In this paper we describe the 
results of a series of scoping reviews undertaken in order to identify patient outcomes that could 
form the basis of a quality measurement system to include monitoring nurse-sensitive outcomes 
in ambulatory cancer chemotherapy. 
Ambulatory chemotherapy is frequently a nurse-led care and treatment management 
environment, where quality of nursing care may potentially have a significant impact on patient 
outcomes and experience. In the UK the quality of services has been identified as variable(Mort 
et al., 2008, National Chemotherapy Advisory Group, 2009), and it seems clear that variable 
quality is an issue in other countries worldwide  (e.g. Malin et al., 2006, Weingart et al., 2007, 
Arora, 2009, Ekwall et al., 2011, Hjörleifsdóttir et al., 2010).  Although the causes of variable 
quality do not relate exclusively to nursing practice, assessment of the quality of care provided by 
*Manuscript (without author details)
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nurses in this context is a high priority because of the role they take in administering therapy and 
providing on-going support and assessment in both the management of toxicities and the 
complex psychosocial challenges faced by patients undergoing cancer treatment.  
There are many potential nurse-sensitive outcomes in ambulatory cancer chemotherapy which 
might provide a focus for assessment of quality by measuring the impact of nursing on patient 
outcomes.  Nurse-sensitive outcomes are defined by the US Oncology Nursing Society (ONS) as 
“...those outcomes arrived at, or significantly impacted, by nursing interventions.” (Given et al., 
2004). The ONS framework gives an indication of many possible outcomes across the broad 
domains of symptom experience, function and safety. Since quality indicators can never fully 
measure „quality‟ as a whole, it is important that across a system there are a range of 
indicators(Mainz, 2003). The ONS definition also raises an important caveat when selecting areas 
to focus on, in that “…interventions [which result in nurse-sensitive outcomes] must be within the 
scope of nursing practice and integral to the processes of nursing care; an empirical link must 
exist.”  Our previous review of outcome metrics in nursing (Griffiths et al., 2008a) identified that 
although claims for the sensitivity of nursing are legion, the empirical basis for such claims is 
often scant and the evidence-base for interventions around even widely accepted nurse-sensitive 
outcomes, such as pressure ulcers, can be surprisingly elusive (Jull and Griffiths, 2010).  
There is no absolute criterion for establishing what constitutes a sufficient evidence base that an 
outcome is nurse-sensitive. Previous reviews have used overviews of intervention studies as 
evidence that an outcome is nurse-sensitive (e.g. , 2003, Gobel et al., 2006) but have applied 
limited research synthesis or formal critical appraisal because of the breadth of the exercises.  It 
is unclear from these whether the nursing interventions represent a fully evidence-based 
approach and are definitively established as sufficiently effective to enter routine practice. It is 
only when this is established that there can be certainty that a good quality nursing service, which 
routinely and effectively uses established effective nursing interventions, can deliver better 
outcomes than one of lower quality. 
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In part because of the difficulty in identifying appropriate patient outcomes for quality 
measurement, there is a significant emphasis on using care processes, as opposed to patient 
outcomes, as quality measures. There is much argument over the relative merits of process and 
outcome measures (Lilford et al., 2004, Donabedian, 2005). Desires within the nursing profession 
for articulation of its important contribution and among the public for improved standards point 
toward outcomes as a significant component of any indicator system, as their importance is more 
clearly understood and harder to contest. Furthermore, since  a process measure is established 
as a measure of quality because its relationship to outcome is known (Donabedian, 1966), the 
starting point for developing any system should be identifying the relevant outcomes. 
Thus this review was undertaken to identify an evidence base for nursing sensitive outcomes in 
ambulatory chemotherapy as a forerunner to developing a set of indicators for use routinely as 
part of quality improvement efforts. The work aimed to replicate the approach taken in our 
previous work(Griffiths et al., 2008b) but with a more detailed focus on this clinical setting. To do 
this we undertook a series of literature reviews in consultation with clinical experts. Because of 
the breadth of the topic area we used scoping review methodologies. Scoping reviews “'aim to 
map rapidly the key concepts underpinning a research area and the main sources and types of 
evidence available… [suitable for] …an area is complex or has not been reviewed 
comprehensively before' P194 (Mays et al., 2001) . The aim of the review was to identify 
outcomes for which there is a strong evidence-base to establish that associated nursing 
interventions should form part of routine nursing practice or outcomes that are strongly 
associated with nursing related organisational characteristics, such as workforce capacity or 
characteristics. Thus we aimed to identify outcomes that would vary with the quality of a nursing 
service either because of its organisational characteristics or because of its use of evidence-
based interventions.  
Methods 
We broadly followed the approach to scoping reviews outlined by Arskey and colleagues(Arksey 
and O'Malley, 2005). The project progressed in 2 stages. 
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Stage 1. The databases Medline, Embase and the British Nursing Index, Google and Google 
scholar were searched to identify indicator systems and potential areas for nurse-sensitive 
outcomes. Searching continued until November 2009. We sought papers that proposed quality 
measures or provided overviews of nurse-sensitive outcomes that could be relevant to 
ambulatory chemotherapy. Searching was iterative but based around a core strategy of 
combinations of terms for “nurse”, “cancer / oncology” and “outcome / quality/ measurement / 
metrics” combined (Boolean „AND‟). Although we focussed our searches on cancer care we 
considered material from other clinical areas where we came across it. Where evidence was 
derived from clinical settings other than ambulatory chemotherapy its relevance was assessed by 
a clinical reference group consisting of senior nurse consultants, specialists and managers of 
ambulatory chemotherapy services.  
Stage 2. We undertook searches of Medline and the Cochrane library for research evidence 
supporting the outcomes that were identified as a priority by the reference group or which were 
identified in a large number of sources during stage 1. The searches were again iterative but 
based around a core structure of keyword / index term for the outcome AND terms for cancer 
AND nurse. We sought primary research evidence from controlled trials or observational studies 
for sensitivity of particular outcomes to known markers of quality and quantity of nursing care (for 
example well-staffed units, units recognised as high quality, units with good leadership or 
teamwork) and we sought systematic reviews or evidence-based guidelines for evidence of 
clearly effective nursing interventions. In seeking evidence for interventions we did not seek to 
comprehensively review all possible interventions for each domain, but rather to identify 
authoritative evidence-based guidance or reviews that addressed outcomes / problems within that 
domain. Therefore we stopped searching and study retrieval once we had identified such a 
source from recent years. As is consistent with our scoping review methodology we did not 
formally assess the quality of each source but we selected only sources that showed evidence of 
a formal process of searching for and selecting evidence and offered explicit quality assessment. 
So for example for fatigue we used a National Institutes of Health „State-of-the-Science‟ 
conference statement(Patrick et al., 2004), a broad systematic overview(Stone, 2002) and three 
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Cochrane reviews on specific interventions (Cramp and Daniel, 2008, Goedendorp et al., 2009, 
Minton et al., 2008). We noted the availability of effective pharmacotherapy because in some 
jurisdictions nurses can prescribe and in other cases access to effective therapy may be 
regulated by referral or other actions by a nurse. 
We assessed the strength of evidence and recommendations using a single simple grading 
system(Guyatt et al., 2006) , selected because it encompassed both the strength of the evidence 
and the associated benefits and because it was consistent with widely endorsed 
recommendations for such systems(GRADE Working Group, 2004) . Evidence was graded as 
high quality, moderate or weak (A-C) depending on the quality and volume of underlying research 
(see table 1) and the recommendation was graded as strong (1) or moderate (2) depending on 
the balance of benefits vs risk or other caveats to applicability. Where guidelines used other 
grading systems, we mapped their recommendations onto this framework. We also considered 
how the evidence related to nursing practice in ambulatory cancer chemotherapy. Based on 
these lines of evidence for a particular outcome we determined whether the outcomes were 
definitely (unambiguous recommendations, strong evidence grade and clear nursing role), likely 
(strong recommendation, moderate evidence), possibly (less strong recommendation / evidence 
or less clear nursing role) or only potentially (scant research evidence but some support) 
sensitive to nursing care.  
Results 
The initial searches yielded 28 sources – mostly published papers but also web sources including 
the sources from the Oncology Nursing Society‟s outcomes resource area at 
(http://www.ons.org/research/outcomes). While many of these sources contained indicator 
statements (giving broad descriptions of attributes of a quality service or its outcomes), we found 
no systems that had developed these into measurement systems relevant to ambulatory 
chemotherapy. We grouped potential indicators into 28 domains (see additional material). The 
domains had varying degrees of generality, depending upon the descriptions found within the 
literature. For example, the „safety‟ domain was identified from literature which described 
Page 6 
Nurse-sensitive outcomes 
 
processes where a number of potential adverse events could result from failures in critical 
aspects of care but the specific events (outcomes) were not necessarily highlighted. For example, 
safe medication administration processes could reduce the consequences of drug errors (both 
toxicity and ineffective treatment), extravasation injury and infection. For some domains, the link 
to outcome was even more general and specific outcomes could not be inferred at any level (e.g. 
workforce knowledge and skill).  
The domains were not mutually exclusive but served to organise the diverse material found. 
Because of the broad scope of the searches and range of potential sources this is unlikely to be a 
completely comprehensive list, but we reached a stage where additional sources ceased to add 
new domains (suggesting saturation of the categories at this level). The initial list was considered 
by the reference group who noted omissions and identified priority areas to review, which they 
viewed as important from a patient or service perspective. Because of limited resources we 
decided to focus on domains where outcomes could be identified and which appeared in six or 
more sources or were identified as priority areas by the reference group. We had anticipated 
using formal consensus methods with the reference group to determine priority areas, but as 
most areas they suggested as priorities were already on our high frequency list we simply added 
other areas that any member of the group identified as a priority.  Although a small number of 
omissions were noted none were identified as priority areas. This gave a list of 11 outcome 
domains (see table 2). The following sections summarise the evidence found for each domain. 
Within each section we discuss how the outcome might be sensitive to nursing service quality. 
Communication & Knowledge 
Patients undergoing cancer chemotherapy face significant challenges and uncertainty. Detailed 
knowledge is required to support self-care  and self-management and is presumed to reduce 
psychological distress(National Comprehensive Cancer Network, 2009) and play a part in 
managing other symptoms such as nausea and vomiting(Naeim et al., 2008, Tipton et al., 2007) 
and pain(Devine, 2003, Syrjala et al., 2008). While studies on the effect of information giving and 
communication in these areas are somewhat equivocal, the provision of accurate information and 
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skilled communication is intrinsically important and makes a major contribution to the quality of 
patient experience(Sitzia and Wood, 1998). Although we identified a systematic review of 
communication skills training, the outcomes reported were changes in professional 
behaviours(Moore et al., 2004). Although changes in nurses‟ communications with simulated 
patients were identified, the significance of this for actual patients is unclear(Moore et al., 2004).  
We found no reviews which measured the impact of variation or training in communication skills 
among nurses on patient knowledge or satisfaction with communication.  
However, a number of interventions intended to impact upon other nurse-sensitive outcomes, 
such as fatigue and septicaemia, act via the mechanism of knowledge and / or rely on effective 
communication skills. In so far as these are supported by evidence the impact upon knowledge 
can be presumed and has been demonstrated in some cases (e.g. Syrjala et al., 2008). Individual 
trials of interventions designed to improve communication skills among nurses(Rask et al., 2009) 
and a nurse-delivered patient information support service (Passalacqua et al., 2009) did not lead 
to improved outcomes (perceived communication quality or satisfaction with knowledge) but in 
neither case was it clear that the intervention was successfully implemented. 
We conclude from this evidence that there is a presumed patient benefit that seems likely to arise 
from a high quality nursing service because a quality service will be more likely than a low quality 
service to identify patient need (through communication skills) and deliver appropriate information 
successfully. However, it may best be regarded as a process indicator, on the pathway to a 
number of important outcomes, and as an element of experience (see below). 
 
Diarrhoea 
The rapidly dividing cells of the gastrointestinal tract render it vulnerable to cytotoxic 
chemotherapy and diarrhoea is a frequent symptom following chemotherapy(Rubenstein et al., 
2004). While there is some evidence to support recommendations (1 A/B) for specific drug 
therapies for the treatment and prevention of diarrhoea or abdominal discomfort(Rubenstein et 
al., 2004) we found no evidence which suggested the impact of nursing interventions or variation 
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in nursing service quality on any measure of diarrhoea or abdominal discomfort. There is an 
assumed patient benefit from a high quality nursing service because a quality service will be more 
likely than a low quality service to identify the patient problem through assessment and ensure 
that recommended therapies are prescribed and so we conclude that the outcome is potentially 
sensitive to nursing.  
Experience 
The experiences that patients have of care are important and represent an essential component 
of quality. Patient experiences of care are also strong indicators of quality care(Donabedian, 
1988) and it is clear that there has been significant variation in the quality of patient experience of 
cancer chemotherapy nursing in the past(Sitzia and Wood, 1998). However, we did not find 
evidence for nursing interventions or aspects of service quality which were clearly associated with 
variation in the patient experience in ambulatory chemotherapy settings, although satisfaction is 
often used as an outcome in nursing intervention studies.  
A single US study compared patient reported outcomes, including satisfaction with care, for 270 
patients cared for by either nurses with a specialist certification in oncology or non-certified 
nurses across several settings including ambulatory settings(Coleman et al., 2009). No 
differences were found in levels of satisfaction associated with certification but the power of the 
study was low, the period of follow up unclear and the design (observational) weak. While the 
literature seems to focus on summary ratings of satisfaction, as opposed to specific reports of 
experience, it seems that provision of information and quality of communication are areas of 
common concern for patients(Sitzia and Wood, 1998). More generally, issues of confidence and 
trust in nursing staff have been highlighted as important aspects of patient experience(Maben and 
Griffiths, 2008).  
The intrinsic nature of experience as both an aspect and an indicator of quality means that 
despite the absence of clear evidence about what nurses do to generate positive (or negative) 
patient experiences, it should be regarded as an indicator of quality that will probably vary with 
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the quality of nursing care. The literature reviewed suggests, but does not clearly identify, from 
the patient‟s point of view, what aspects of experience matter most.  
Fatigue 
Fatigue is a nearly universal experience among patients undergoing cytotoxic chemotherapy 
although specific causes are poorly understood(Wagner and Cella, 2004), probably because so 
many factors converge for the patient undergoing treatment for cancer. Factors leading to fatigue 
include direct effects of the tumour, treatment side effects, co-morbid conditions, co-morbid 
symptoms and psychological strain. There is some evidence (grade B/C) from reviews, including 
high quality systematic reviews, supporting exercise, psychosocial interventions and drug therapy 
for patients with anaemia (Wagner and Cella, 2004, Patrick et al., 2004, Stone, 2002, Cramp and 
Daniel, 2008, Goedendorp et al., 2009, Minton et al., 2008). Patients might also benefit indirectly 
from therapies targeted at specific problems such as breathlessness(Bredin et al., 1999) . 
From this we conclude that the outcome is possibly sensitive to the quality of nursing because a 
quality service will be more likely than a low quality service to identify the patient problem through 
assessment and ensure that recommended therapies are prescribed. There is a potential direct 
effect from nurse-delivered non-pharmacological therapies. The potential involvement of nurses 
in delivering psychosocial interventions is high but these may not form part of routine care, 
instead comprising additional sessions over a short (10 minutes) to long (3 hours) duration and 
delivered over a number of weeks (see for example (Armes et al., 2007)).  
Nausea & Vomiting 
Nausea and vomiting are common and distressing symptoms associated with most 
chemotherapy regimens. Although the effectiveness of drug treatments is well established(Naeim 
et al., 2008, Tipton et al., 2007) (1A) the benefits of other therapies and the direct contribution of 
nursing is not, although a number of potential nursing interventions are supported by grade 1-2 
B/C recommendations. These include pre-assessment, targeted screening, structured follow 
up(Naeim et al., 2008), and interventions such as acupuncture, acupressure, guided imagery, 
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music, progressive muscle relaxation, support and information (Naeim et al., 2008, Klein and 
Griffiths, 2004). Generally, careful assessment, matching preventative regimes to likely need (1B) 
and provision of dietary advice (2C) may have an impact upon the outcome. 
Although process measures showed some difference no differences in patient reported nausea 
were associated with being cared for by nurses with certification in oncology compared to non-
certified nurses in an observational study, but this study suffered from a number of weaknesses 
(see section on Experience) including low power(Coleman et al., 2009). A multi centre 
observational (pre-post) study of 249 chemotherapy patients found some evidence (grade C) of 
improvement in nausea and vomiting from the implementation of an evidence-based clinical 
practice protocol identifying interventions for nurses combined with structured symptom 
assessment(Kearney et al., 2008). 
As with fatigue, the evidence suggests that patients will probably benefit from a high quality 
nursing service because a quality service will be more likely than a low quality service to identify 
the patient problem through assessment and ensure that recommended therapies are prescribed. 
There is a potential direct effect from nurse-delivered non-pharmacological therapies such as the 
provision of advice on self-care, some of which would readily form part of routine practice.  
Nutrition 
Patients with cancer often present with anorexia and weight loss due to the disease process and 
may subsequently suffer further challenges due to treatment side effects. In relation to 
ambulatory chemotherapy treatment, induced nausea and vomiting are key contributing 
factors(Brown, 2002). We found no strong evidence to support the sensitivity of this outcome to 
nursing. There is some evidence from a good quality systematic review to support the use of 
appetite stimulant drugs for people with cancer(Yavuzsen et al., 2005) (grade B). A review of 
interventions, including nutritional supplementation and counselling, provided some limited 
evidence of improved nutrition and wellbeing(Brown, 2002) (grade B/C).  
Benefit from a high quality nursing service might be assumed because nurses will be more likely 
to identify the patient problem through assessment, ensure that recommended therapies are 
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prescribed and appropriate advice and support given. However, the effectiveness of these 
treatments is supported by only modest evidence.  
Oral Mucositis 
Oral mucositis is a common and potentially debilitating side effect of many common 
chemotherapy regimes. It is associated with significant adverse outcomes such as infection and 
death(Rubenstein et al., 2004). Good oral care and client education is recommended and seen as 
a core part of the nursing role although precise protocols vary hugely and strong evidence of 
effect is lacking (Grade 1/2C)(Rubenstein et al., 2004). There are a number of potentially effective 
agents for treating mucositis but evidence is weak and of poor quality (Grade B)(Clarkson et al., 
2007). There is stronger (but variable) evidence for preventative interventions likely to be nurse-
led or based on advice from nurses, including the use of; honey (grade B), ice chips (grade A), 
and oral care (grade B). A multi-centre observational study of patients undergoing chemotherapy 
gave some evidence (grade C) of improvement in oral symptoms from the implementation of an 
evidence-based clinical practice protocol for nurses(Kearney et al., 2008).  
From the evidence we conclude that patients might benefit from a high quality nursing service 
because a quality service will be more likely identify problems through assessment and ensure 
that recommended preventative actions are taken There is also a potential direct effect from 
nurse-delivered non-pharmacological therapies which could form part of routine practice, 
including provision of advice on self-care.  
 
Pain 
Pain is a common and debilitating symptom associated with cancer although estimates of its 
prevalence in the population as a whole vary greatly with little data available on incidence(Patrick 
et al., 2004, Breivik et al., 2009). Given that many patients undergoing cancer chemotherapy may 
be asymptomatic, having had tumours detected via screening programmes, or not had pain as a 
presenting symptom(Breivik et al., 2009) it is likely that prevalence is lower in this population than 
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the general population of people with cancer. Apart from local discomfort it is not a treatment side 
effect although pain progression or reduction may be an indicator of treatment effectiveness. 
There is a substantial literature on approaches to pharmacological management of pain and 
many guidelines(Caraceni et al., 2009) which are recommended for practice (level 1) but 
management of pain is often suboptimal(Breivik et al., 2009).  There is evidence from a number 
of trials and observational studies that use of such guidelines results in reduced levels of pain for 
patients (e.g. (Zech et al., 1995, Du Pen et al., 1999), evidence level A/B), but we could find no 
high quality systematic reviews of guideline implementation for this clinical topic. Patient training 
and information giving is also recommended (level 1) and associated with improved pain 
management in several trials and a systematic review(Devine, 2003, Syrjala et al., 2008) 
although results are not consistent (grade B).There is also evidence (grade B) from a systematic 
review to support psychological interventions such as guided imagery(Devine 2003). No 
differences in outcome were found associated with specialist certification of nurses but the study 
design was weak (see section on experience) (Coleman et al., 2009).  
A high quality nursing service will be more likely to identify this patient problem through 
assessment and ensure that recommended therapies are prescribed. There is a possible direct 
effect from nurse-delivered non-pharmacological therapies thorough provision of advice on self-
care although the precise nursing role in the ambulatory chemotherapy setting is somewhat 
unclear, since it is not a problem that is directly related to treatment, and it is likely that much of 
the care would be delivered elsewhere. As with fatigue management it may well also be that 
psychosocial interventions require additional therapy to be delivered outside the routine clinical 
encounter (see for example Yates et al., 2004) 
Safe medication administration 
The administration of medication is a high risk activity and drug errors are common(Walsh et al., 
2009). When the medications being administered are cytotoxic the risk of harm is particularly 
high. While drug errors are primarily related to systems failures, nurses have a role in detection 
and prevention before harm is done to the patient(Walsh et al., 2009).  Furthermore, the 
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administration process itself is risky requiring skilled assessment of patient fitness and patency of 
intravenous access(Walsh et al., 2009).  Patient education is a key challenge for patients 
receiving oral medication where a lack of concordance poses a significant risk(Jacobson et al., 
2009).  Many of the potential impacts of nursing relate to assessment of toxicities(Walsh et al., 
2009) and are reflected in other outcomes considered in this review (e.g. nausea and vomiting, 
mucositis, septicaemia).  Administration of vesicant drugs poses a significant risk associated with 
many commonly used drugs(Wickham et al., 2006).  We found no specific evidence from reviews 
relating to nursing interventions or approaches to increase safety in ambulatory chemotherapy 
but there are strong expert recommendations(Jacobson et al., 2009, Wickham et al., 2006, 
Wengström and Margulies, 2008) (level1 C) and evidence-based recommendations on 
intravenous drug administration from general settings (level 1 A/B) relating to the safe 
administration of medication which points to diverse aspects of assessment (including fitness to 
receive drugs) and technique (including prevention of infection and the treatment and prevention 
of injury from vesicant drugs) which fall within the scope of nursing practice. Evaluation (before 
and after) of a multifaceted nurse-led programme designed to increase the quality of care related 
to chemotherapy-related toxicities(Moore et al., 2008) showed sub optimal care processes at 
initiation of the project and resulted in improvements in those processes but the study did not 
report patient outcomes. 
This outcome is therefore probably sensitive to nursing intervention and overall service quality. 
There is presumed patient benefit from a high quality nursing service because a quality service 
will be more likely than a low quality service to properly assess and reduce errors and adverse 
reactions and ensure that recommended preventative actions are taken.  A high quality service is 
also more likely to identify and remedy contributing factors. There is a potential direct effect from 
nursing technique (hygiene, assessment and correct use/placement of devices) which form part 
of routine practice.  
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Septicaemia / Febrile Neutropaenia 
Febrile neutropaenia is a common and life-threatening complication of many chemotherapy 
regimens(Krell and Jones, 2009, Cameron, 2009). Delays in treatment and reductions in dose are 
common, resulting in reduced treatment effectiveness(Cameron, 2009). There is a role for 
chemo-prophylaxis and treatment with antibiotics(Cameron, 2009). However, much emphasis is 
placed on patient education, self-care and appropriate support and assessment(Cameron, 2009). 
Preventative actions by patients are believed to impact on rates of infection but specifics of 
appropriate advice are contested(Nirenberg et al., 2006) (level 2 C). The provision of telephone 
support, including dedicated help lines (generally by nurses) is common(Cameron, 2009), but we 
could find no reports of the impact of these on outcomes. There is considerable uncertainty 
around the appropriate content for self-care  advice(Nirenberg et al., 2006). However, there is 
evidence of variation in both practice and in outcomes(Mort et al., 2008, Nirenberg et al., 2006). 
Early self-referral when experiencing symptoms is a key action believed to impact on 
outcomes(Cameron, 2009). 
The outcome is thus identified as nurse-sensitive because it is assumed that patients benefit from 
a high quality nursing service because it will be more likely than a low quality service to reduce 
risk, educate patients appropriately, provide referral guidance and appropriate advice and 
support. Although outside the scope of practice in many areas nurses may also ensure that 
recommended prophylactic therapies are prescribed and taken. However the appropriate advice 
and support mechanisms remain uncertain. 
Wellbeing & Function 
A sense of wellbeing and the ability to perform normal activities and roles are severely challenged 
by both the direct consequences of cancer, the psychological sequelae of diagnosis and the 
physical and psychological impact of treatments, which include toxicities associated with cancer 
chemotherapy. Prevalence of major depression may be as high as 42% among people with 
cancer(Patrick et al., 2004) although there is huge variation in estimates. Much of the variation in 
functional outcomes for individuals is likely to be mediated by psychological wellbeing and by the 
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impact of toxicities. The frequent suggestion of benefit of psycho-educational interventions for 
diverse symptoms such as fatigue, nausea and pain clearly suggests that the causal pathway is 
complex. Sleep disturbance is also heavily implicated in the complex causal pathway(Reich, 
2008, Clark et al., 2004). We could find no studies specifically addressing nursing interventions to 
support physical or role function. Guidelines support screening for distress, education, 
counselling and identifying those in need of onward referral as interventions (Grade 1 B/C) 
(National Comprehensive Cancer Network, 2009) all of which could be delivered by nurses in the 
ambulatory chemotherapy setting, but the evidence base is modest or weak. A systematic 
review(Osborn et al., 2006) identified evidence for benefits from cognitive behaviour therapy for 
depression and anxiety (grade A). A review of interventions for sleep disturbance suggest that 
mindfulness based stress reduction techniques and expressive writing may have some benefit on 
sleep in diverse groups of people with cancer but no evidence derives from those receiving 
current chemotherapy (grade B). Individual trials of interventions designed to improve 
communication skills among nurses(Rask et al., 2009) and a nurse-delivered patient information 
support service(Passalacqua et al., 2009) did not lead to reductions in patient‟s expressed 
wellbeing but in neither case was it clear that the intervention was successfully implemented. 
Thus there is an assumed patient benefit from a high quality nursing service because a quality 
service will be more likely to identify patient problems and ensure that actions are taken. A high 
quality nursing service is also more likely to identify and remedy contributing factors including 
specific side effects such as nausea and vomiting. There is a potential direct effect from nurse-
delivered non-pharmacological therapies some of which could form part of routine practice 
although many would need to be delivered as part of a programme of support similar to 
interventions for fatigue and evaluation of brief interventions is limited(Turner et al., 2011).  
Discussion & conclusions 
We did not identify any existing outcomes based systems of quality measurement that focussed 
on nursing sensitive outcomes relevant to ambulatory cancer chemotherapy. There have been 
attempts to develop such systems in other ambulatory settings (e.g. Griffin and Swan, 2006) but 
Page 16 
Nurse-sensitive outcomes 
 
the generic outcomes identified there were not highly relevant to this specific setting. We 
identified a large number of outcomes potentially sensitive to nursing in ambulatory cancer 
chemotherapy. Our focussed scoping of evidence around a shortlist of possible outcomes 
suggested that the evidence to support a link between nursing and outcomes was often relatively 
weak. While there are many trials of nursing interventions, we found relatively little clear evidence 
that would establish the interventions as fully supported by evidence (i.e. clear evidence of effect 
derived from a high quality systematic review of trials) sufficient to use as a routine quality 
measure. Although we have not assessed evidence for all possible outcomes identified we 
assessed those where the claims for sensitivity to nursing could be said to be strongest, based on 
the frequency they appeared in our sources and the priority ascribed by clinicians in our reference 
group.  
In acute care settings the sensitivity of a range of outcomes to nursing has been established 
through observational studies which show relationships between outcomes and presumed 
dimensions of service quality such as leadership, training, staffing levels (Aiken et al., 2008, 
Aiken et al., 2003, Aiken et al., 2002). Similar findings have been shown in surgical oncology 
settings (Friese et al., 2008). We found little equivalent evidence for ambulatory chemotherapy  
and although we did identify one observational study exploring the specialist certification of 
nurses (Coleman et al., 2009) the small size of the study renders its failure to show associations 
between specialist training and patient outcome rather uninformative. Although we did not identify 
any evidence that would allow factors such as staffing level or training to be considered as direct 
quality indicators these factors are heavily implicated in variations in quality in other settings. We 
would recommend that any system developed to monitor or demonstrate the quality of nursing 
care incorporated measures and reports of contextual factors including level and skill mix of nurse 
staffing, specialist qualifications of nurses and quality of the practice environment. 
In many cases the nursing contribution to patient outcomes was based upon a presumed link 
between accurate problem identification and provision of access to therapies (some nurse-
delivered, some not) with modest direct evidence of actual benefit from actions by nurses. In 
several cases the degree of sensitivity to nursing would depend upon the precise roles nurses 
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fulfil within a setting. For example, if nurses act as independent prescribers for treatments of 
toxicities then patient outcomes are likely to be more dependent on the input of nurses than if 
they are not. If nurses were not administering intravenous medications then many aspects of safe 
medication administration we identified would not be „nurse-sensitive‟ at all. On the other hand, 
we have not considered evidence of outcomes that may reflect and be sensitive to care from the 
wider clinical team who provide supportive care for patients undergoing cancer chemotherapy. 
Under some circumstances this support (for example nutritional support) could be primarily 
provided by nurses. However, where a nursing role was significantly developed we would have 
expected such outcomes to be identified in our searches (as it was for nutrition) and so, while we 
might have missed potential contributions of nurses, it seems unlikely that nurses are routinely 
providing these services or that substantial evidence exists of benefit associated with nurses, 
since if there was we would have expected to see it represented in the results of our searches or 
recommendations from our reference group. 
Evidence from acute settings makes it clear that not all outcomes that are sensitive to nursing 
could usefully be adopted as nurse-sensitive quality measures. The apparent oxymoron – an 
outcome sensitive to nursing that is not a nurse-sensitive outcome – is an important distinction. 
Consider for example mortality. There is considerable evidence that establishes that a significant 
amount of the variation in inpatient mortality is associated with registered nurse staffing levels 
(Kane et al., 2007). Clearly, the outcome is sensitive to nursing. However, it seems unlikely that 
nursing (on its own) makes the largest contribution to inpatient mortality. After adjusting for 
patient level factors, the contribution of the medical profession in identifying the best treatments 
and competently performing appropriate procedures is likely to be the single biggest determinant 
of a hospital‟s death rate and evidence of staffing outcome associations support this view 
(Jarman et al., 1999). Therefore if used as a quality measure, while nursing should certainly be 
considered, it is not specifically implicated in variation in the outcome.  
However, this point highlights a significant limitation in our review. We have not attempted to 
assess how much variation in patient outcome is associated with nursing. Where large scale 
observational studies show associations with nursing quality factors, these associations can be 
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used to assess the degree of variability that is associated with nursing. This can be extended to 
assess the degree of variation compared to other factors and thus assess the likely utility of the 
outcome as a direct measure of quality(Mant, 2001).  Alternatively, if there are robust estimates of 
the relative benefit associated with an evidence-based intervention this too can be used. 
However, no suitable studies were found to make such estimates. Consistent with our scoping 
review methodology we did not undertake systematic reviews of individual interventions. Rather 
we relied on existing reviews. This could also mean that there are interventions and outcomes for 
which such evidence does exist but which have not yet been systematically reviewed. However, 
until such research is undertaken neither we nor the practice community can judge what the 
conclusion of such a review would be, and so we do not see this as a limitation to our work per 
se. However, more focussed and comprehensive searching on individual interventions might yet 
yield additional evidence from reviews. 
The outcomes identified and evidence reviewed suggests that the clearest direct impact of nurses 
in ambulatory chemotherapy is likely to be on the safety and experience dimensions of quality. 
Any nursing impact on treatment effectiveness is primarily indirect and is largely mediated by 
nurses‟ ability to support patients in managing the toxicities of treatment. In our previous report on 
metrics(Griffiths et al., 2008b) we identified the importance of involving patients in identifying 
important aspects of experience that should be assessed. Some important issues have been 
raised in this review which could act as a focus. Provision of information and quality of 
communication have in the past been identified as significant areas of concern for patients (Sitzia 
and Wood, 1998) and clearly seem to remain prominent issues (Arora, 2009). While much of the 
relevant research has utilised the broad term „patient satisfaction‟, this is unhelpful as satisfaction 
scores are only weakly associated with specific and important aspects of patient experience 
(Jenkinson et al., 2002). What is essential is to specifically identify what experiences matter to 
patients. 
Conclusion 
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The rhetoric of nursing‟s influence on important patient outcomes in this area is not currently 
matched by the strength evidence base.  We found that patient experience, nausea and vomiting, 
oral mucositis and safe medication administration were the outcome areas most likely to be 
sensitive to nursing in ambulatory cancer chemotherapy, based on the lines of evidence 
considered. Communication and provision of information to patients are likely to be important 
mechanisms in achieving these outcomes. Our next step is to develop a prototype set of 
indicators and pilot these across a number of ambulatory chemotherapy units focussed on 
enabling their routine and standardised collection at the point of care to support continuous 
improvements to the quality of nursing care. 
 
In coming to this conclusion we do not imply that other outcomes are unimportant or not 
amenable to nursing interventions. It is simply that the evidence available does not support their 
use for quality measurement. It may be that other outcomes are less easily attributable to nursing 
specifically. Consideration of a wider range of outcomes could contribute to a broader suite of 
cancer care (as opposed to treatment) outcomes. Within this suite, the purpose of identifying 
some as specifically nurse-sensitive would be to give clear responsibility and clinical leadership to 
nurses for monitoring and acting on results. Just as delivering the best surgical outcomes require 
an informed, engaged, quality ward nursing team, the delivery of optimal nursing outcomes in 
ambulatory cancer chemotherapy will still require the involvement of the wider multidisciplinary 
team.  
While there is considerable scope for routine collection of patient reported outcomes to be used 
to develop an evidence-base for interventions and approaches to service delivery  and thus to 
rectify limitations(Wheeler et al., 2010), caution must be adopted when selecting areas for quality 
measurement, since these form a basis on which the quality of a service is judged. The aim of 
identifying quality measures is to measure quality, not to set a research agenda and, in so far as 
any system of measurement is liable to be used as a performance measure, the empirical basis 
of the claim that an outcome is sensitive to nursing is a crucial consideration. To put it simply, if 
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nurses are to be held accountable for an outcome and the quality of nursing services judged 
because of it, the evidence base for the link between nursing and that outcome should be clear. 
However, although we have cautioned against including areas where the evidence base is weak 
in routine quality measures this weakness in evidence also highlights the need for further 
research, both observational and experimental, to guide nursing intervention and organisation of 
nursing services.  
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Table 1 Evidence grading (based on Guyatt et al 2006) 
Grade Type of evidence 
A high-quality evidence RCTs without important limitations or 
overwhelming evidence from observational 
studies 
B moderate quality evidence RCTs with important limitations (inconsistent 
results, methodological flaws, indirect, or 
imprecise) or exceptionally strong evidence 
from observational studies  
C low-quality or very low-quality evidence Observational studies or case series 
 
Table
 Table 2 Summary of consensus and evidence assessments 
Outcome Recommendati
on/ evidence 
Assessment of 
sensitivity to 
nursing 
Communication and 
Knowledge  
1B Likely 
Diarrhoea 1 A/B Possible 
Experience - Likely 
Fatigue       (1)B/C Possible 
Nausea and vomiting 1A/B Likely 
Nutrition B/C Possible 
Oral mucositis 1ABC Likely 
Pain 1A/B Possible 
Safe medication 
administration 
1C Likely 
Septicaemia 2C Possible 
Wellbeing and function 1B/C Possible 
 
 
 
Potential quality outcome domains    
 
Outcomes (domain) Example indicator areas 
Anaemia
1 2
 Assessment for related symptoms 
2
 
Cardiac toxicity Assessment using validated tool
3
 
Constipation
4-7
 Assessment of bowel habits using validated tools
8
 
 Constipation
4-7
 
 Dietary assessment
6
 
Diarrhoea
1 4 7
 Altered mucous membranes
3-5
 
 Assessment of bowel habits using validated tool
8
 
 Diarrhoea
1 4 7
 
Dyspnoea
4-6 9
 Assessment of dyspnoea using validated tools
6 8 10
 
 Dyspnoea
4-6
 
 Patient education for managing dyspnoea
6
 
 Patient support for managing dyspnoea
6
 
Education & Communication Emergency support phone line manned 24/7 
3
 
 Family education
8 16 18
 
 Patient knows contacts (emergency & other) during 
chemo 
3 19
 
 Patient education re: treatment/processes/side 
effects/what to do/febrile neutropaenia/holistic 
assessment/contacts – who and how 
3 8 16 18 19 24
 
 Patient satisfaction with education 
21
 
 Staff communication with family
18
 
 Staff communication with patient 
18
 
Experience Control of treatment choices
9
 
 Patient choice about place of treatment 
3
 
 Patient feel there is trusted relationship with staff 
20 21
 
 Patient satisfied with way staff communicate to them
19 20
  
 Patient confidence in staff
20
 
 Patient involvement in care and treatment
19
 
 Patient knows contacts (emergency & other) during 
chemo 
3 19
 
 Patient satisfaction with technical care 
3 18 19
 
 Patient satisfaction with nurse management – symptom 
management, information giving & support 
3 21 22
 
 Patients wait time (wait for treatment)
3 19 23
 
 Support at home available 
3
 
Family well being Emotional strain on family/caregiver
6
 
 Family education
6
 
 Family support
18
 
 Psychological counselling
18
 
 Routine assessment of anxiety routinely using validated 
tool
8
 
Fatigue
4-6
 Ability to undertake ADLs
4 5 11 12
 
 Assessment of fatigue using validated tool
6 10
 
Fertility
3
 Fertility counselling 
Hypertension
3
 Assessment of BP
3
 
Hypersensitivity reactions
4 5
 Rash
3
 
(Oral) Mucositis
4 6 13
 Assessment for infection (fungal/herpes)
13
 
 Assessment of nutritional status (weight loss/anorexia/ 
malnutrition/ dehydration)
6 7 10
  
 Assessment of oral cavity regularly using validated tools
6 
13
 
 Clear and regular documentation
6
 
 Has pt been told to use soft bristle toothbrush & replace 
supplementary material (online only)
Appendices 
it regularly? 
6 14
 
 Infection 
 Nutritional Status
6 7 10
 
 Patient education about specifics of oral hygiene in 
mucositis 
6 13
 
 Patient education about the use of oral care protocols
13 
14
  
 Referral to dental professional
6 14
 
Nausea & Vomiting 
1 4-6 9
 Assessment – frequency/intensity  
 Counselling anxious patients 
6
 
 Frequency/intensity of nausea (pt report) 
4
 
 Nutritional assessment
7
 
 Prescription of appropriate antiemetic regime
6
 
 Pt education 
6
 
 Regular assessment and documentation using validated 
tools (self-reporting where possible)
6
 
Nutrition
7
 Assessment from first point of contact and then ongoing 
using validated tool
6 10
 
 Cachexia
10
 
 Care plan developed from point of contact
6
 
 Malnourished
6 10
 
 Nutritional counselling
10
 
 Oral mucositis 
13
 
Pain
4-6 8 16
 Assessment of pain using validated tools
6
 
 Education interventions 
6
 
 Level of pain assessed using validated tools 
1 6 8 17
 
 Patient comfort level
7 18 19
 
 Referrals to other services such as massage providing 
short term relief 
6
 
Peripheral Neuropathy 
(chemotherapy induced)
4 6
 
Hand and foot syndrome (Palmar-Plantar 
Erythrodysesthesia)
3
 
 Regular assessment of physical condition monitoring of 
symptoms
6
 
 Routine assessment of stance, gait & balance
6
 
Septicaemia Assessment for signs of infection 
15
 
 Avoidance of permanent or semi permanent catheters 
 Early identification
3 15
 
 Febrile neutropaenia
3-6 15
 
 Frequent oral care (tooth brushing & gentle flossing as 
tolerated)
6 15
 
 (Oral) Mucositis
4 6 13
 
 Patient education
3 15
 
Skin ulcer
5 11 12
 Skin ulcer
5 11 12
 
Sleep disturbances/ Insomnia
4 5
 Sleep disturbances/ Insomnia
4 5
 
Wellbeing & Function Ability to carry out usual activities
4 5 11 12
 
 Activities of Daily Living (ADL)
4 5 18
 
 (Patient) Anxiety
4-6 18 19
 
 Anxiety assessment using validated tool 
3
 
 Assessment of fatigue using validated tool
6 10
 
 Compliance 
3 20
 
 Coping
4 7 18
 
 Depression
4-6 10 18
 
 Fatigue
4-6
 
 Instrumental Activities of Daily Living (IADL)
4 5 18
 
 Needle phobia assessment 
3
 
 Patient-family communication
9 18
 
 Performance status
3 12
 
 Psychological counselling
6
 
 Quality of life
5 6
 
 Return to usual function
4 18
 
 Routine assessment of anxiety using validated tool
6 8
 
 Routine assessment of depression using validated tool
6
 
 Sleep disturbances/ Insomnia
4 5
 
 Spiritual care services available 
8
 
 Spiritual distress
4 5 9
 
 
Safety 
Outcome Indicator 
Safety
12
 Availability of hand washing facilities/hygiene 
 Cleanliness of environment 
19 20
 
 Nosocomial infection
25
 
 Patient education re: treatment/processes/side 
effects/what to do/febrile neutropaenia/holistic 
assessment/contacts – who and how
3 8 16 18 19 24
  
 Reporting of incidents/near misses
22 26
 
Safe medication administration Aseptic technique used at all times for IV insertion to any 
site
6
 
 Avoidance of permanent or semi permanent catheters
6
 
 Barrier precautions taken when inserting central venous 
catheters
6
 
 Catheter type/size assessed for complications – type & 
duration of IV therapy
27
 
 Catheters replaced no more frequently than 72 hours 
unless otherwise indicated 
6
 
 Central line associated blood stream infection 
22 25
 
 Cleanliness of environment 
19 20
 
 Clear documentation of care plan
6
 
 Dressings over IV sites changed promptly when 
soiled/damp or loosened 
6
 
 Extravasation incidents
5 24 27
 
 Insertion site assessed for possible complications
6 24 27
 
 Intravenous Infection
27
 
 Needle phobia assessment 
3
 
 Number of central lines/IV lines 
 Number of days central lines in place
6
 
 Number of incidents
3 22
 
 Nurse canulating to administer drug 
3
 
 Nurse knowledge
18 24 27
 
 Nurse skill
18 27
 
 Paediatric IV infiltration rate 
 Patient education re: treatment/processes/side 
effects/what to do/febrile neutropaenia/holistic 
assessment/contacts – who and how 
3 8 16 18 19 24 27
 
 Phlebitis rate 
3 24
 
 Re-admission: length of stay with toxicity
3 5 18
  
 Reporting of incidents/near misses
22 26
 
 Safety standards for devices
20 24
 
 Sclerosis of central line sites 
3
 
 Septicaemia
3 15
 
 Vein pain
3 24 27
 
 Venous assessment (specifically those on vesicants)
3 24
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Processes, structures and workforce 
Outcome Indicator 
Care Delivery processes Advocacy for pt/family
18
 
 Care planning
8
 
 Continuity of care
8
 
 Correct nursing diagnosis
18
 
 Improved documentation
8 18
 
 Patients wait time (wait for treatment)
3 19 23
 
 Referrals to resources
8 18 19 23
 
 Use of guidelines/policy 
3 24
 
 Use of research
6 18
 
Internal Regulations/Compliance Compliance with organisations safety standards
20 24
 
 Use of guidelines/policy 
3
 
 Internal regulations
18
 
 Safety standards for devices
20 24
 
Resource Utilisation Emergency visits
4 20 23
 
 Homecare Visits
4
 
 Out-of-pocket-costs (family)
4 5
 
 Re-admission: length of stay with toxicity 
3 5 18
 
Workforce organisation / 
management  
Staff support (staff/peer/administrative)
18 23
 
 Identified lead nurse 
28
 
 Practice Environment 
26
 
 Team working 
26
 
 Leadership
26
 
Workforce Resources Lack of personnel
18
 
 Nursing hours per patient/day
21
 
 Nurse retention
18
 
 Nurse turnover
23 25
 
 Practice environment (size, space, patient comfort, 
privacy) 
19 25 26
 
 Staffing levels: number of nurses to workload 
3
 
 Staff mix: Health care support worker/nurse grade/band 
3
 
 Waiting time for treatment
3 19 20
 
Workforce Skill & Knowledge Nurse knowledge
18 24
 
 Nurse skill
18
 
 RN certification (level 3 training accredited course) 
3
 
 RN education
3
 
 Staff mix: Health care support worker/nurse grade/band 
3 
23 25
 
Workforce Wellbeing Job satisfaction
18 21 23 25
 
 Perceived lack of time 
3 18
 
 Multiple job expectations
18
 
 Practice Environment Scale 
26
 
 Staff communication – interdisciplinary (with each other 
and/or pt/family)
8 18
 
 Nurse retention[18] 
 Nurse turnover
23 25
 
 Staff resistance 
18
 
 Staff support (staff/peer/administrative)
18 23
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 The ‘long list’ of domains  
Topic Number of 
sources 
Priority Areas 
identified by 
reference group 
Wellbeing & Function 13 ** 
Safe Medication Administration 12 ** 
Safety 9  
Care Delivery Processes 8  
Pain 8  
Education & Communication 7 * 
Workforce Resources 7  
Workforce Wellbeing 7 * 
Diarrhoea 6 ** 
Fatigue 6  
(Oral) Mucositis 6 * 
Dyspnea 5  
Experience 5  
Nausea & Vomiting 5 ** 
Resource Utilisation 5  
Septicaemia 5 ** 
Workforce Skill & Knowledge 5  
Constipation 4  
Internal Regulations/Compliance 4  
Nutrition 4 * 
Workforce Organisation / Management 4  
Family Well Being 3  
Hypersensitivity Reactions 3  
Peripheral Neuropathy (chemotherapy induced) 3  
Skin Ulcer 3  
Anaemia 2  
Sleep Disturbances/ Insomnia 2  
Cardiac Toxicity 1  
Fertility 1  
Hypertension 1  
(items marked ** received higher prioritisation than those with *)
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Appendix 4:   The ‘shortlist’ of outcome areas 
Topic Ranking (based 
on number of 
sources) 
Wellbeing & Function 1 
Safe Medication Administration 2 
Pain 3 
Education & Communication 4 
Diarrhoea 5 
Fatigue 6 
(Oral) Mucositis 7 
Patient Experience 8 
Nausea & Vomiting 9 
Septicaemia 10 
Nutrition 11 
 
Appendix 5.  Suggestions for Specific Indicators of Safety and 
Effectiveness  
Table 5 Suggested indicators 
Measure Source of 
Measure 
Numerator Denominator Exclusions Notes 
Safe medication 
administration 
     
Incidence of 
extravasation of 
cytotoxic drug 
per thousand 
treatment cycles 
Safety 
reporting 
systems 
All reported 
incidents of 
extravasation 
All patients 
receiving IV 
cytotoxic 
chemotherapy 
per cycle 
Patients on 
oral only 
medication 
Possible issues of under 
reporting or recording. 
Ambiguity when 
‘suspected’ 
Extravasation 
resulting in 
ulceration per 
thousand 
treatment cycles 
Safety 
reporting 
systems 
All reported 
incidents of 
extravasation 
All patients 
receiving IV 
cytotoxic 
chemotherapy 
per cycle 
Patients on 
oral only 
medication 
Possible issues of under 
reporting / recording. 
Needs risk adjustment for 
regimen 
Patient report of 
pain or irritation 
at the infusion 
site per thousand 
treatment cycles 
Patient self 
report 
Patients reporting 
pain, irritation or 
discomfort at a 
previous infusion 
site on or since the 
previous infusion. 
All patients 
receiving IV 
cytotoxic 
chemotherapy 
per cycle 
Patients 
attending for 
first cycle of 
chemotherapy 
Potential for recall or 
presentation bias. Will 
require a standard 
mechanism for recording 
and collating 
Other issues / 
areas 
     
Drug 
administration 
errors 
Safety 
reporting 
systems 
? ?  Unclear the extent to which 
available measures relate 
to nursing role 
Drug errors Safety 
reporting 
systems 
? ?  Unclear the extent to which 
available measures relate 
to nursing role 
Management of 
toxicities 
     
Documented 
Assessment of 
severity of 
nausea and 
vomiting (% per 
treatment cycle) 
Clinical 
record audit 
All patients 
attending for 
chemotherapy 
treatment with a 
record of the 
severity of nausea 
and vomiting after 
last treatment 
cycle 
All patients 
attending for 
chemotherapy 
treatment 
Patients 
attending for 
first cycle of 
chemotherapy 
Documented assessment 
does not necessarily lead 
to improved outcomes. 
Could be labour intensive 
Patients 
reporting severe 
nausea following 
treatment (% per 
treatment cycle) 
Patient self 
report 
All patients 
reporting ‘severe’ 
nausea after last 
treatment using 
the C-SAS
83
 item / 
assessed at 
attendance for 
chemotherapy 
All patients with 
assessments 
recorded 
Patients 
attending for 
first cycle of 
chemotherapy 
Will require a standard 
mechanism for recording 
and collating. Will require 
risk adjustment. Choice of 
denominator may lead to 
adverse conclusions if 
recording / reporting is 
selective. Will need to be 
risk adjusted for regimen 
Severe vomiting 
following 
treatment (% per 
treatment cycle) 
Patient self 
report 
All patients 
reporting ‘severe’ 
vomiting after last 
treatment using 
the C-SAS
83
 item / 
assessed at 
attendance for 
chemotherapy 
All patients with 
assessments 
recorded 
Patients 
attending for 
first cycle of 
chemotherapy 
Will require a standard 
mechanism for recording 
and collating. Will require 
risk adjustment. Choice of 
denominator may lead to 
adverse conclusions if 
recording / reporting is 
selective. Will need to be 
risk adjusted for regimen 
 
